WINNIPEG, MB, May 5, 2021 /CNW/ - Medicure Inc.
("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF),
a company focused on the development and commercialization of
pharmaceuticals and healthcare products for patients and
prescribers in the United States
market, will release financial results for the quarter ended
March 31, 2021 on Monday, May 10, 2021. The first quarter financial
statements will be made available on the Company's website at
www.medicure.com. Medicure will hold a conference call and webcast
regarding the 2020 annual and Q1 2021 results on Tuesday, May 11, 2021 at 7:30 AM Central Time (8:30
AM Eastern Time).
Conference Call Info:
Topic: Medicure's 2020 Annual and Q1 2021 Results
Call date: Tuesday, May 11, 2021
Time: 7:30 AM Central Time (8:30 AM
Eastern Time)
Canada toll: 1 (416)
764-8659
North American toll-free: 1 (888) 664-6392
Passcode: not required
Webcast: This conference call will be webcast
live over the internet and can be accessed from the Medicure
investor relations page at the following link:
http://www.medicure.com/investors
You may request international country-specific access
information by e-mailing the Company in advance. Management will
accept and answer questions related to the financial results and
operations during the question-and-answer period at the end of the
conference call. A recording of the call will be available
following the event at the Company's website.
About Medicure Inc.
Medicure is a pharmaceutical
company focused on the development and commercialization of
therapies for the U.S. cardiovascular market. The present focus of
the Company is the marketing and distribution of
AGGRASTAT® (tirofiban hydrochloride) injection and
ZYPITAMAG® (pitavastatin) tablets in the United States, where they are sold through
the Company's U.S. subsidiary, Medicure Pharma Inc. Medicure also
operates Marley Drug, Inc. ("Marley"), a pharmacy located in
North Carolina that offers an
Extended Supply mail order drug program serving 49 states,
Washington D.C. and Puerto Rico. Marley is committed to improving
the health status of its patients and the communities they serve
while reducing overall health care costs for employers and other
health care consumers. For more information visit
www.marleydrug.com. To learn more about The Extended Supply Generic
Drug Program call 800.286.6781 or email
info@marleydrug.com. For more information on Medicure please
visit www.medicure.com. For additional information about
AGGRASTAT®, refer to the full Prescribing Information.
For additional information about ZYPITAMAG®, refer to
the full Prescribing Information.
To be added to Medicure's e-mail list, please visit:
http://medicure.mediaroom.com/alerts
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
View original
content:http://www.prnewswire.com/news-releases/medicure-2020-annual-and-q1-2021-results-and-conference-call-date-301284836.html
SOURCE Medicure Inc.